APG or TRAIL single therapy or untreated control displayed tissue necrosis interspersed with viable tumor cells, whereas APG and TRAIL combined treatment induced large areas of continuous necrosis within tumors (Fig. 8a). The gene discussed is TNFSF10; the disease is neoplasm.